Hypertriglyceridemia (High Triglycerides)
Hypertriglyceridemia, also called high triglycerides, is a metabolic condition in which triglyceride levels are elevated. It describes the condition itself rather than a particular supplement, medication, or treatment approach.
Hypertriglyceridemia is the medical term for high triglycerides, classified here as a metabolic condition.
This list shows research findings, not treatments. Nothing here replaces medical care. If you have this condition, talk to a doctor.
What may help
None of these options has good evidence yet. Best evidence first.
3 options:1 not enough evidence2 not tested in people
Cupping TherapypracticeNot enough evidence
Too few or too small studies to know if it works.
The one study found a benefit.
A 2024 case report involving 1 person described potential reductions in triglycerides and pancreatitis episodes.
Open the Cupping Therapy pageCardiopracticeNot tested in people
Only tested in animals, cells or theory. Results like these often do not carry over to people.
The one study found a benefit.
Open the Cardio pageFastingpracticeNot tested in people
Only tested in animals, cells or theory. Results like these often do not carry over to people.
The one study found a benefit.
Intermittent fasting may lower triglycerides in adults with overweight or metabolic syndrome, potentially through weight loss and improved insulin sensitivity. Evidence in severe hypertriglyceridemia is lacking.
Open the Fasting page
The expert view shows every study, dose protocol and source.
What may help
Interventions recorded as helping with this condition3 listedThe best we have, but the evidence is still weak
- →PracticesCupping TherapyCertaintyLowSourceClinical
A 2024 case report involving 1 person described potential reductions in triglycerides and pancreatitis episodes.
Who was studied
- People with a condition
- Hypertriglyceridemia
- Pancreatitis
Open Cupping TherapyStudy result
Case report showing potential reduction in triglycerides and pancreatitis episodes.
- →PracticesCardioCertaintyLowSourceTheoretical
Aerobic exercise lowers fasting triglycerides, most clearly when sustained at sufficient weekly volume.
- →PracticesFastingCertaintyLowSourceTheoretical
Intermittent fasting may lower triglycerides in adults with overweight or metabolic syndrome, potentially through weight loss and improved insulin sensitivity. Evidence in severe hypertriglyceridemia is lacking.
Open FastingStudy result
Intermittent fasting may modestly lower triglycerides in adults with overweight or metabolic syndrome, largely through weight loss and improved insulin sensitivity. Evidence in severe hypertriglyceridemia is lacking.
What to avoid
Interventions recorded as making it worseNothing in this library is currently recorded as making Hypertriglyceridemia (High Triglycerides) worse. Coverage is partial, and absence here is not evidence of safety.
How to read the evidence
Evidence tier — overall strength of the evidence for the whole compound
- StrongWell established — backed by strong, consistent human research.
- ModerateSome genuine support, but mostly from small or lower-quality studies. Promising, not proven.
- PreliminaryEarly-stage evidence — a promising hypothesis, not an established effect yet.
- LimitedVery limited evidence — treat this as a hypothesis, not proof.
- InsufficientNot enough good evidence to draw conclusions yet.
Certainty — how sure we can be that the effect is real
- Very highVery sure — strong, consistent evidence
- HighFairly sure — consistent evidence from good studies
- MediumModerately sure — new studies could change this
- LowNot sure — little or mixed evidence
- Very lowVery unsure — almost no usable evidence
Source — where the data comes from
- Meta-analysisPooled analysis of many trials — the strongest evidence
- RCTRandomized controlled trial — a strong human study design
- ClinicalA human clinical study
- Reference knowledgeFrom general health-science or pharmacology references, not a study of this exact claim
- Animal researchStudied in animals, not humans
- Community reportsAggregated user reports — anecdotal signal, not evidence
- TheoreticalMechanism-based reasoning, not yet tested
Study grade — quality of each underlying study (A best, D weakest)
- AHigh-quality — strong, consistent human trials
- BGood — solid evidence with some limitations
- CModerate — limited, small, or mixed-quality studies
- DWeak — preliminary, indirect, or animal-only
Confidence — how strongly the sources back a finding
A 0–100 score from study quality and agreement
Most supplement evidence is graded C–D. Read it as preliminary signal, not proof.
Full write-up
What is it
Hypertriglyceridemia, also called high triglycerides, is a metabolic condition in which triglyceride levels are elevated. It describes the condition itself rather than a particular supplement, medication, or treatment approach. Options discussed in relation to it include Omega-3, Krill Oil, Vitamin B3 (Niacin), and Berberine, but these references do not make the condition interchangeable with any of them. Because hypertriglyceridemia is a medical condition, interpretation and management are best considered with a clinician.
Evidence-backed options
The options associated with Hypertriglyceridemia (High Triglycerides) are not supported equally. Omega-3 has the clearest clinical support, with findings indicating a consistent reduction in triglyceride levels across the available research. This evidence includes people with mixed health status, so its applicability may vary between individuals and clinical circumstances.
Support for the other options is thinner. Several are identified in pharmacology references as possible therapeutic or adjunctive options, but the information presented does not establish comparable direct clinical support. The available clinical finding for Krill Oil did not show a significant reduction in triglycerides among individuals with slightly elevated levels, so it should not be treated as interchangeable with Omega-3 on the basis of the evidence summarized here.
The information available does not establish a shared dose, treatment duration, or time to onset across these options. It also does not show that an option with a lower evidence assessment can replace guideline-directed lipid therapy. Interpretation should therefore account for the severity of triglyceride elevation, the population studied, and the difference between reference-based use and findings from clinical research. A clinician can help place these options in the context of an individual medical condition and treatment plan.